Table 3.

Adjusted multivariable analysis for predictors of portal vein thrombosis at the time of liver transplantation

	Odds ratio	95%CI	P value
African American race	0.75	0.64-0.89	< 0.001
AIH	1.43	1.14-1.79	0.002
Hispanic race	1.24	1.10-1.39	< 0.001
HR-NASH	2.11	1.60-2.76	< 0.001
LR-NASH	1.71	1.49-1.96	< 0.001
Male gender	1.18	1.07-1.29	< 0.001
Moderate-severe ascites	1.14	1.04-1.25	0.007

Recipients with HR-NASH had the greatest risk of pre-transplant PVT when referenced both to the non-NASH cohort and to LR-NASH recipients. Variables that were not significant in the model: Albumin levels, bilirubin levels, cholestatic liver disease, creatinine levels, hepatitis C, international normalized ratio (INR); moderate-severe encephalopathy, pre-transplant dialysis treatment, sodium levels. AIH: Autoimmune hepatitis; HR: High-risk; LR: Low-risk; NASH: Non-alcoholic steatohepatitis.